A company in Singapore has developed a breathalyser test for Covid-19 which it says will let people know if they’re infected in less than a minute.
Breathonix, a startup firm from the National University of Singapore, says its test achieved more than 90% accuracy in a pilot clinical trial of 180 people in the city-state and hopes to get regulatory approval early next year.
Countries worldwide are looking to develop alternative tests to the Polymerase Chain Reaction (PCR) nasal swab, which is invasive and in short supply in some places where demand has outstripped manufacturers’ production capacity.
Breathonix is currently expanding its trial in Singapore and hopes to improve accuracy and get the green light to go commercial in the first quarter of next year. (Metro)